Cantor Fitzgerald’s Medicus Sciences Acquisition Corp MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-98,630
Closed -$993K – 825
2022
Q4
$993K Hold
98,630
– – 0.02% 396
2022
Q3
$976K Hold
98,630
– – 0.02% 435
2022
Q2
$965K Buy
+98,630
New +$967K 0.02% 475

Cantor Fitzgerald's MSAC Position: Q1 2023 in Review

Cantor Fitzgerald sold out of Medicus Sciences Acquisition Corp (MSAC) in Q1 2023, closing a stake of 98,630 shares — an estimated $993K sold.

Cantor Fitzgerald first reported a position in MSAC in Q2 2022 and held it in 3 quarters. The position peaked at $993K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

  • Cantor Fitzgerald reported no remaining Medicus Sciences Acquisition Corp position as of Q1 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 98,630 Medicus Sciences Acquisition Corp shares in Q1 2023, an estimated $993K.
  • Cantor Fitzgerald first reported a position in Medicus Sciences Acquisition Corp in Q2 2022 and held it in 3 quarters.
  • Cantor Fitzgerald's Medicus Sciences Acquisition Corp position peaked at $993K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp as of Q1 2023.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.